Takeda to partner on patient-centric data with SeqsterTakeda has partnered with patient data firm Seqster in a drive to improve care through better access and Share XTakeda to partner on patient-centric data with Seqsterhttps://pharmaphorum.com/news/takeda-to-partner-on-patient-centric-data-with-seqster/
Sidekick Health raises $20m to fund digital therapeutics expansionGamified digital therapeutics firm Sidekick Health has raised $20 million in a Series A funding round, which it Share XSidekick Health raises $20m to fund digital therapeutics expansionhttps://pharmaphorum.com/news/sidekick-health-raises-20m-to-fund-digital-therapeutics-expansion/
NHS strikes another deal with clinical AI company Sensyne HealthSensyne Health has signed a five-year non-exclusive Strategic Research Agreement (SRA) with Milton Keynes University Hospital NHS Foundation Share XNHS strikes another deal with clinical AI company Sensyne Healthhttps://pharmaphorum.com/news/nhs-strikes-another-deal-with-sensyne-health/
Novartis launches digital health hub in CanadaNovartis is opening a new digital health innovation hub in Canada to help develop “scalable, digital solutions” for Share XNovartis launches digital health hub in Canadahttps://pharmaphorum.com/digital/novartis-launches-digital-health-hub-in-canada/
Akili presents new real-world data from therapeutic ADHD video gameAkili has new data from its childhood hyperactivity therapeutic video game EndeavorRx, as the company builds a case Share XAkili presents new real-world data from therapeutic ADHD video gamehttps://pharmaphorum.com/news/akili-presents-new-real-world-data-from-therapeutic-adhd-video-game/
On-skin printing of sensors could monitor COVID-19 symptomsScientists say on-skin printing could be used to create on-body sensors to monitor physiological signals and devices to Share XOn-skin printing of sensors could monitor COVID-19 symptomshttps://pharmaphorum.com/news/on-skin-printing-of-sensors-could-monitor-covid-19-symptoms/
COVID-19 ventilator demand fuels Philips Q3 salesHuge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced. The Share XCOVID-19 ventilator demand fuels Philips Q3 saleshttps://pharmaphorum.com/news/covid-19-ventilator-demand-fuels-philips-q3-sales/
UK trials digital ‘health passport’ to help borders reopenRegular fliers are used to long queues to clear security – but a rigorous COVID-19 testing regime could Share XUK trials digital ‘health passport’ to help borders reopenhttps://pharmaphorum.com/news/uk-trials-digital-health-passport-to-help-borders-reopen/
Boehringer, Yale trial digital tech in heart failurePatients with heart failure often have a dismal prognosis as the condition usually worsens over time, but a Share XBoehringer, Yale trial digital tech in heart failurehttps://pharmaphorum.com/news/boehringer-yale-trial-digital-tech-in-heart-failure/
